Pervasip (OTCMKTS:PVSP – Get Free Report) and USANA Health Sciences (NYSE:USNA – Get Free Report) are both small-cap utilities companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.
Analyst Ratings
This is a summary of current ratings and target prices for Pervasip and USANA Health Sciences, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Pervasip | 0 | 0 | 0 | 0 | 0.00 |
USANA Health Sciences | 0 | 1 | 0 | 0 | 2.00 |
USANA Health Sciences has a consensus price target of $35.00, indicating a potential downside of 6.19%. Given USANA Health Sciences’ stronger consensus rating and higher probable upside, analysts plainly believe USANA Health Sciences is more favorable than Pervasip.
Institutional and Insider Ownership
Valuation and Earnings
This table compares Pervasip and USANA Health Sciences”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Pervasip | $15.77 million | 0.09 | -$2.35 million | N/A | N/A |
USANA Health Sciences | $921.01 million | 0.77 | $63.79 million | $2.83 | 13.18 |
USANA Health Sciences has higher revenue and earnings than Pervasip.
Profitability
This table compares Pervasip and USANA Health Sciences’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Pervasip | -16.98% | N/A | -21.52% |
USANA Health Sciences | 6.30% | 10.64% | 8.48% |
Risk and Volatility
Pervasip has a beta of -0.33, meaning that its share price is 133% less volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500.
Summary
USANA Health Sciences beats Pervasip on 10 of the 11 factors compared between the two stocks.
About Pervasip
Pervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York.
About USANA Health Sciences
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Pervasip Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pervasip and related companies with MarketBeat.com's FREE daily email newsletter.